Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Equity

Artiva Biotherapeutics (ARTV) EBIT Margin (2023 - 2024)

Historic EBIT Margin for Artiva Biotherapeutics (ARTV) over the last 2 years, with Q1 2024 value amounting to 5773.71%.

  • Artiva Biotherapeutics' EBIT Margin changed N/A to 5773.71% in Q1 2024 from the same period last year, while for Dec 2024 it was 26806.37%, marking a year-over-year change of. This contributed to the annual value of 26805.58% for FY2024, which is 267140000.0% down from last year.
  • As of Q1 2024, Artiva Biotherapeutics' EBIT Margin stood at 5773.71%.
  • Artiva Biotherapeutics' EBIT Margin's 5-year high stood at 40.56% during Q3 2023, with a 5-year trough of 5773.71% in Q1 2024.